Financhill
Back

BioLine Rx Stock Predictions

BioLine Rx Stock Forecast

  • Is BioLine Rx Stock Undervalued?
    The current BioLine Rx [BLRX] share price is $0.55. The Score for BLRX is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • BLRX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will BioLine Rx Stock Go Up Next Year?

Data Unavailable

BioLine Rx Stock Rating

Data Unavailable

BioLine Rx Stock Price History

Is BLRX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLRX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Israel
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biolinerx.com

52-Week Data

52-Week High:
1.89
52-Week Low:
0.39

Prediction Charts

Market Cap:
43.59M
Price in USD:
0.55
Volume:
346.06K
Beta:
1.76

Technical Analysis

SMA50:
0.51
SMA100:
0.61
SMA200:
0.73
52-Wk Change:
-67.93%

Stock Predictions

  • Is BioLine Rx stock public?
    Yes, BioLine Rx is a publicly traded company.
  • What is the BioLine Rx stock quote today?
    The BioLine Rx stock price is 0.55 USD today.
  • How to buy BioLine Rx stock online?
    You can buy BioLine Rx shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-1 0.40 0.43 0.43 0.40
Nov-4 0.41 0.43 0.45 0.41
Nov-5 0.42 0.44 0.47 0.42
Nov-6 0.45 0.45 0.47 0.43
Nov-7 0.43 0.45 0.45 0.43
Nov-8 0.45 0.44 0.45 0.44
Nov-11 0.44 0.45 0.46 0.43
Nov-12 0.43 0.43 0.45 0.43
Nov-13 0.43 0.45 0.46 0.43
Nov-14 0.45 0.46 0.48 0.44
Nov-15 0.48 0.48 0.48 0.45
Nov-18 0.49 0.46 0.49 0.44
Nov-19 0.47 0.54 0.55 0.47
Nov-20 0.53 0.55 0.57 0.52

BioLine Rx Earnings

Data Unavailable

BioLine Rx Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and a decrease next year of $0.10 per share.

* BioLine Rx stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.